More News
3 September 2019
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine3 September 2019
RIKEN and Astellas Enter into Worldwide Exclusive Licensing Agreement for Artificial Adjuvant Vector Cell Technology in Oncology28 August 2019
Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies28 August 2019
Machavert Pharmaceuticals Signs Exclusive License Agreement to Control RAL GTPase Inhibitors against KRAS Cancers28 August 2019
Ionis licenses hepatitis B program to GSK27 August 2019
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion22 August 2019
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China14 August 2019
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome13 August 2019
Pharming acquires exclusive license to CDZ173, a late stage drug for the treatment of APDSNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports